Semnur Pharmaceuticals Inc Quick Ratio (SMNR) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Semnur Pharmaceuticals Inc   (SMNR)

Semnur Pharmaceuticals Inc 's Quick Ratio

SMNR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0 a new company low.

Within Major Pharmaceutical Preparations industry 449 other companies have achieved higher Quick Ratio than Semnur Pharmaceuticals Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 4290 to 4481.

Explain Quick Ratio?
How much Cash & cash equivalents SMNR´s has?
What are SMNR´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SMNR Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 62.47 % 32.2 % 553.65 % 52.14 % -0.39 %
Y / Y Cash & cash equivalent Change -84.4 % 3664.62 % 630.99 % 494.95 % 1649.84 %
Quick Ratio MRQ 0 0.01 0 0.01 0.04
SMNR's Total Ranking # 4481 # 4290 # 4505 # 3978 #
Seq. Current Liabilities Change 2.81 % 2.08 % 1.36 % 52.72 % -16.34 %
Seq. Cash & cash equivalent Change -62.14 % 415 % -76.47 % -66 % 9037.43 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 450
Healthcare Sector # 918
Overall Market # 4481


Quick Ratio Statistics
High Average Low
10.85 1.17 0
(Sep 30 2022)   (Mar 31 2024)




Financial Statements
Semnur Pharmaceuticals Inc 's Current Liabilities $ 11 Millions Visit SMNR's Balance sheet
Semnur Pharmaceuticals Inc 's Cash & cash equivalent $ 0 Millions Visit SMNR's Balance sheet
Source of SMNR's Sales Visit SMNR's Sales by Geography


Cumulative Semnur Pharmaceuticals Inc 's Quick Ratio

SMNR's Quick Ratio for the trailling 12 Months

SMNR Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 82.77 % 64.41 % 66.9 % 7.09 % -0.88 %
Y / Y Cash & cash equivalent TTM Growth -8.44 % 1245.24 % 1006.75 % 45.45 % 22.73 %
Quick Ratio TTM 0.01 0.01 0.01 0.01 0.01
Total Ranking TTM # 4156 # 3258 # 3050 # 3367 #
Seq. Current Liabilities TTM Growth 11.05 % 7.3 % 33.11 % 15.23 % -0.11 %
Seq. Cash & cash equivalent TTM Growth -46.07 % 28.03 % 5.07 % 26.21 % 692.34 %

Quick ratio ranking by company, industry and sector >> Back to SMNR Financial Strength Comparisons >> Go to Compare SMNR Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q2 2026 to $10.67 millions, cumulative Quick Ratio remained unchanged at 0.01 below the Semnur Pharmaceuticals Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 444 other companies have achieved higher Quick Ratio than Semnur Pharmaceuticals Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3258 to 4156.

Explain Quick Ratio?
How much Cash & cash equivalents SMNR´s has?
What are SMNR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 445
Healthcare Sector # 916
Within the Market # 4156


trailing twelve months Quick Ratio Statistics
High Average Low
0.77 0.09 0
(Mar 31 2023)   (Jun 30 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Os Therapies Incorporated  0.01 $ 0.205  Millions$ 20.653  Millions
The Greater Cannabis Company Inc   0.01 $ 0.000  Millions$ 0.012  Millions
Chemocentryx Inc.  0.01 $ 1.253  Millions$ 139.868  Millions
NIKA PHARMACEUTICALS, INC  0.01 $ 0.003  Millions$ 0.341  Millions
Evofem Biosciences Inc   0.01 $ 0.714  Millions$ 88.615  Millions
Rain Enhancement Technologies Holdco Inc   0.01 $ 0.071  Millions$ 13.574  Millions
IMPACT BIOMEDICAL INC. 0.00 $ 0.010  Millions$ 2.045  Millions
Semnur Pharmaceuticals Inc 0.00 $ 0.039  Millions$ 10.672  Millions
Cnbx Pharmaceuticals Inc 0.00 $ 0.010  Millions$ 2.673  Millions
Accustem Sciences Inc 0.00 $ 0.013  Millions$ 5.724  Millions
Skinvisible Inc 0.00 $ 0.004  Millions$ 5.174  Millions

Date modified: 2026-09-26T07:41:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.